 <!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v1.1 20031101//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article"><?scanned_data?><?from_PubMed?><front><journal-meta><journal-id journal-id-type="nlm-ta">Nucleic Acids Res</journal-id><journal-title>Nucleic Acids Research</journal-title><issn pub-type="ppub">0305-1048</issn><issn pub-type="epub">1362-4962</issn></journal-meta><article-meta><article-id pub-id-type="pmid">7479001</article-id><article-id pub-id-type="pii">5c0091</article-id><article-categories><subj-group><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Differential regulation of plasminogen activator and inhibitor gene transcription by the tumor suppressor p53.</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Kunz</surname><given-names>C</given-names></name></contrib><contrib contrib-type="author"><name><surname>Pebler</surname><given-names>S</given-names></name></contrib><contrib contrib-type="author"><name><surname>Otte</surname><given-names>J</given-names></name></contrib><contrib contrib-type="author"><name><surname>von der Ahe</surname><given-names>D</given-names></name></contrib></contrib-group><aff>Haemostasis Research Unit, Kerckhoff-Klinik, Max-Planck-Institut, Bad Nauheim, Germany.</aff><pub-date pub-type="ppub"><day>25</day><month>9</month><year>1995</year></pub-date><volume>23</volume><issue>18</issue><fpage>3710</fpage><lpage>3717</lpage><abstract><p>The ability of p53 to activate or repress transcription suggests that its biological function as tumor suppressor is in part accomplished by regulating a number of genes including such required for inhibition of cell growth. We here give evidence that p53 also may regulate genes responsible for the proteolytic degradation of the extracellular matrix, which is considered a crucial feature for local invasion and metastasis of neoplastic cells. An important and highly regulated cascade of such proteolytic events involves the plasminogen activator system. We show that wild-type p53 represses transcription from the enhancer and promoter of the human urokinase-type (u-PA) and the tissue-type plasminogen activator (t-PA) gene through a non-DNA binding mechanism. Oncogenic mutants lost the repressing activity. In contrast, wild-type but not mutant p53 specifically binds to and activates the promoter of the plasminogen activator inhibitor type-1 (PAI-1) gene. Interestingly, one of the p53 mutants (273his) inhibited PAI-1 promoter activity. Our results suggest that altered function of oncogenic forms of p53 may lead to altered expression of the plasminogen activators and their inhibitor(s) and thus to altered activation of the plasminogen/plasmin system during tumor progression.</p><sec><title>Images</title><fig id="F1"><graphic xlink:href="nar00018-0113-a" xlink:role="3715"/></fig><fig id="F2"><graphic xlink:href="nar00018-0114-a" xlink:role="3716"/></fig><fig id="F3"><graphic xlink:href="nar00018-0115-a" xlink:role="3717"/></fig></sec></abstract></article-meta></front><body><supplementary-material content-type="scanned-pages"><graphic xlink:href="nar00018-0108.tif" xlink:title="scanned-page" xlink:role="3710"/><graphic xlink:href="nar00018-0109.tif" xlink:title="scanned-page" xlink:role="3711"/><graphic xlink:href="nar00018-0110.tif" xlink:title="scanned-page" xlink:role="3712"/><graphic xlink:href="nar00018-0111.tif" xlink:title="scanned-page" xlink:role="3713"/><graphic xlink:href="nar00018-0112.tif" xlink:title="scanned-page" xlink:role="3714"/><graphic xlink:href="nar00018-0113.tif" xlink:title="scanned-page" xlink:role="3715"/><graphic xlink:href="nar00018-0114.tif" xlink:title="scanned-page" xlink:role="3716"/><graphic xlink:href="nar00018-0115.tif" xlink:title="scanned-page" xlink:role="3717"/></supplementary-material></body></article> 